Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa. (academic.oup.com)

Authors: Dorward J … Garrett N Journal: Clinical Infectious Diseases Published: 2026-03-04 DOI: https://doi.org/10.1093/cid/ciag155